Floatz logo

25 assets in Systemic Sclerosis

Therapeutic assets addressing Systemic Sclerosis, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Bcma-Cd19 Ccar T Cells
Systemic Sclerosis
Peking University People's HospitalP2CCC (53)
Jnj-78436735
Systemic Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (53)
Moderna Covid-19 Vaccine Rna
Systemic Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (53)
Monovalent [B.1.351] Cov2 Pres Dtm-As03
Systemic Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (53)
Sildenafil
Systemic Sclerosis
Topadur Pharma AGP2CCC (53)
Tibulizumab
Systemic Sclerosis
Zura Bio IncP2CCC (53)
Top-N53
Systemic Sclerosis
Topadur Pharma AGP2CCC (53)
Methotrexate
Systemic Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (51)
Tozinameran
Systemic Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (50)
Ucar T-Cell
Systemic Sclerosis
The Children's Hospital of Zhejiang University School of MedicineP1CCC (48)
Homodimeric Fragment Crystallizable Fusion Protein Comprised Of The Extracellular Domain Of The Human Transforming Growth Factor Beta Receptor Type Ii Linked To A Human Igg1 Fc Domain
Systemic Sclerosis
Merck Sharp & Dohme LLCP1CC (47)
ro7303509
Systemic Sclerosis
Genentech, Inc.P1CC (47)
Autologous Cd19-Bcma Dual-Target Car T-Cell Therapy
Systemic Sclerosis
Beijing Boren HospitalP1CC (43)
azd0120
Systemic Sclerosis
AstraZenecaP1CC (43)
bnt162b2
Systemic Sclerosis
National Institute of Allergy and Infectious Diseases (NIAID)P2CC (43)
Cabozantinib
Systemic Sclerosis
National Cancer Institute (NCI)P1CC (43)
hbi0101 cart
Systemic Sclerosis
Polina StepenskyP1CC (43)
Ipilimumab
Systemic Sclerosis
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Systemic Sclerosis
National Cancer Institute (NCI)P1CC (43)
her2bbζ/cd19t+ t cells
Systemic Sclerosis
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Early P1C (39)
qt-219cx
Systemic Sclerosis
The Children's Hospital of Zhejiang University School of MedicineEarly P1C (39)
RD06-05 CART Cell
Systemic Sclerosis
The Children's Hospital of Zhejiang University School of MedicineEarly P1C (39)
Varinon
Systemic Sclerosis
Primus PharmaceuticalsN/AD (30)
Vixarelimab
Systemic Sclerosis
Genentech, Inc.P2NR ()